$TBRA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Tobira Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Tobira Therapeutics, Inc.. Get notifications about new insider transactions in Tobira Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2015 | TBRA | Tobira Therapeutic ... | Cooper Jeffrey H | Director | Option Exercise | A | 8.13 | 13,539 | 110,072 | 13,539 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Frazier Healthcare V, LP | 10% Owner | Grant | A | 0.00 | 2,668,570 | 0 | 2,668,570 | 0 to 2.7 M |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Option Exercise | A | 2.96 | 4,332 | 12,823 | 4,332 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Heron Patrick J | Director | Grant | A | 0.00 | 2,668,570 | 0 | 2,668,570 | 0 to 2.7 M |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 4.81 | 18,956 | 91,178 | 31,952 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 3.51 | 4,332 | 15,205 | 12,996 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 3.14 | 4,332 | 13,602 | 8,664 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Brosgart Carol L | Director | Option Exercise | A | 4.25 | 4,332 | 18,411 | 4,332 | |
| May 06 2015 | TBRA | Tobira Therapeutic ... | Novo A/S | 10% Owner | Buy | P | 10.62 | 838,041 | 8,899,995 | 2,696,405 | 1.9 M to 2.7 M (+45.10 %) |
| May 06 2015 | TBRA | Tobira Therapeutic ... | DOMAIN ASSOCIATES | 10% Owner | Buy | J | 0.00 | 36,187 | 0 | 38,094 | 1.9 K to 38.1 K (+1,897.59 %) |
| May 06 2015 | TBRA | Tobira Therapeutic ... | DOMAIN PARTERS VII L P | 10% Owner | Buy | P | 10.62 | 277,777 | 2,949,992 | 3,553,322 | 3.3 M to 3.6 M (+8.48 %) |
| Jan 06 2015 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Mendelsohn Michael | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Elsey R Don | Sr. VP/Chief Financ ... | Option Exercise | A | 0.91 | 92,902 | 84,541 | 92,902 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Jan 05 2015 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 0.91 | 159,261 | 144,928 | 159,261 | |
| Dec 24 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Sell | S | 1.10 | 941,252 | 1,035,377 | 3,214,955 | 4.2 M to 3.2 M (-22.65 %) |
| Dec 24 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Sell | S | 1.08 | 18,748 | 20,248 | 4,156,207 | 4.2 M to 4.2 M (-0.45 %) |
| Dec 24 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Sell | S | 1.10 | 100,000 | 110,000 | 4,174,955 | 4.3 M to 4.2 M (-2.34 %) |
| Dec 24 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Sell | S | 1.06 | 10,000 | 10,600 | 4,274,955 | 4.3 M to 4.3 M (-0.23 %) |
| Dec 05 2014 | TBRA | Tobira Therapeutic ... | Metzger Michael A | President & CEO | Option Exercise | A | 0.85 | 837,531 | 711,901 | 837,531 | |
| Jun 16 2014 | TBRA | Tobira Therapeutic ... | Fromkin Andrew J. | Director | Option Exercise | A | 6.47 | 51,000 | 329,970 | 51,000 | |
| May 21 2014 | TBRA | Tobira Therapeutic ... | Pelliccione Nicholas J. | Sr. VP of Regulator ... | Option Exercise | A | 5.46 | 100,000 | 546,000 | 100,000 | |
| May 07 2014 | TBRA | Tobira Therapeutic ... | Elsey R Don | Sr. VP/Chief Financ ... | Option Exercise | A | 6.36 | 250,000 | 1,590,000 | 250,000 | |
| Apr 17 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | P | 6.00 | 575,000 | 3,450,000 | 4,284,955 | 3.7 M to 4.3 M (+15.50 %) |
| Mar 25 2014 | TBRA | Tobira Therapeutic ... | BVF PARTNERS L P/IL | Option Exercise | J | 5.00 | 2,632 | 13,160 | 2,632 | ||
| Mar 25 2014 | TBRA | Tobira Therapeutic ... | BVF PARTNERS L P/IL | Option Exercise | J | 5.00 | 4,577 | 22,885 | 4,577 | ||
| Mar 25 2014 | TBRA | Tobira Therapeutic ... | BVF PARTNERS L P/IL | Sell | J | 0.00 | 526,436 | 0 | 1,121,221 | 1.6 M to 1.1 M (-31.95 %) | |
| Mar 25 2014 | TBRA | Tobira Therapeutic ... | BVF PARTNERS L P/IL | Sell | J | 0.00 | 915,345 | 0 | 1,979,670 | 2.9 M to 2 M (-31.62 %) | |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | X | 0.17 | 1 | 0 | 0 | |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | X | 4.51 | 1 | 5 | 0 | |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | X | 4.51 | 1 | 5 | 0 | |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | X | 3.34 | 1 | 3 | 0 | |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | X | 0.17 | 4,491 | 763 | 1,130,133 | 1.1 M to 1.1 M (+0.40 %) |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | X | 4.51 | 3,341 | 15,068 | 1,125,642 | 1.1 M to 1.1 M (+0.30 %) |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | X | 4.51 | 5,447 | 24,566 | 1,122,301 | 1.1 M to 1.1 M (+0.49 %) |
| Mar 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | X | 3.34 | 2,095 | 6,997 | 1,116,854 | 1.1 M to 1.1 M (+0.19 %) |
| Feb 06 2014 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | P | 5.00 | 400,000 | 2,000,000 | 3,700,955 | 3.3 M to 3.7 M (+12.12 %) |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Rusconi Christopher Paul | Chief Scientific Of ... | Option Exercise | A | 4.77 | 73,000 | 348,210 | 73,000 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Courts Christopher | Vice President of F ... | Option Exercise | A | 4.77 | 23,000 | 109,710 | 23,000 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Giaquinto Alexander R | CCO, SVP of Reg. Af ... | Option Exercise | A | 4.77 | 38,000 | 181,260 | 38,000 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Zelenkofske Steven | SVP & Chief Medical ... | Option Exercise | A | 4.77 | 75,000 | 357,750 | 75,000 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Mazzo David J | Chief Executive Off ... | Option Exercise | A | 4.77 | 180,000 | 858,600 | 180,000 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Legault Pierre | Director | Option Exercise | A | 4.77 | 4,820 | 22,991 | 4,820 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Mendelsohn Michael | Director | Option Exercise | A | 4.77 | 4,820 | 22,991 | 4,820 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Jan 03 2014 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 4.77 | 9,640 | 45,983 | 9,640 | |
| Dec 20 2013 | TBRA | Tobira Therapeutic ... | Metzger Michael A | President and COO | Option Exercise | A | 4.81 | 434,008 | 2,087,578 | 434,008 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | RMI Investments S.a.r.l. | 10% Owner | Option Exercise | C | 0.00 | 22,878,805 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | RMI Investments S.a.r.l. | 10% Owner | Buy | P | 4.00 | 3,866,529 | 15,466,116 | 5,236,517 | 1.4 M to 5.2 M (+282.23 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | RMI Investments S.a.r.l. | 10% Owner | Buy | C | 0.00 | 1,369,988 | 0 | 1,369,988 | 0 to 1.4 M |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | C | 0.00 | 807,652 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | C | 0.00 | 7,769,715 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | C | 0.00 | 4,566,908 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | C | 0.00 | 6,666,667 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Buy | P | 4.00 | 71,810 | 287,240 | 1,294,021 | 1.2 M to 1.3 M (+5.88 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Buy | C | 0.00 | 48,362 | 0 | 1,222,211 | 1.2 M to 1.2 M (+4.12 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Buy | C | 0.00 | 465,252 | 0 | 1,173,849 | 708.6 K to 1.2 M (+65.66 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Buy | C | 0.00 | 273,468 | 0 | 708,597 | 435.1 K to 708.6 K (+62.85 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | NEFF P SHERRILL | Director | Buy | C | 0.00 | 399,201 | 0 | 435,129 | 35.9 K to 435.1 K (+1,111.11 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Zelenkofske Steven | SVP & Chief Medical ... | Option Exercise | A | 4.00 | 225,552 | 902,208 | 225,552 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Option Exercise | C | 0.00 | 10,750,105 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Option Exercise | C | 0.00 | 23,261,013 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Option Exercise | C | 0.00 | 3,324,136 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Option Exercise | C | 0.00 | 1,670,833 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Option Exercise | C | 0.00 | 3,369,811 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 3,300,955 | 2.6 M to 3.3 M (+29.40 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | C | 0.00 | 634,718 | 0 | 2,550,955 | 1.9 M to 2.6 M (+33.12 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | C | 0.00 | 1,392,875 | 0 | 1,916,237 | 523.4 K to 1.9 M (+266.14 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | C | 0.00 | 199,050 | 0 | 523,362 | 324.3 K to 523.4 K (+61.38 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | C | 0.00 | 100,050 | 0 | 324,312 | 224.3 K to 324.3 K (+44.61 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | KIERLIN ROBERT A | 10% Owner | Buy | C | 0.00 | 201,785 | 0 | 224,262 | 22.5 K to 224.3 K (+897.74 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Option Exercise | C | 0.00 | 2,832,872 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Option Exercise | C | 0.00 | 17,066,243 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Buy | P | 4.00 | 1,215,708 | 4,862,832 | 2,407,271 | 1.2 M to 2.4 M (+102.03 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Buy | C | 0.00 | 169,633 | 0 | 1,191,563 | 1 M to 1.2 M (+16.60 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Wisniewski Raphael | Director | Buy | C | 0.00 | 1,021,930 | 0 | 1,021,930 | 0 to 1 M |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 807,652 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 7,769,715 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 4,566,908 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Option Exercise | C | 0.00 | 6,666,667 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | P | 4.00 | 71,810 | 287,240 | 1,294,021 | 1.2 M to 1.3 M (+5.88 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | C | 0.00 | 48,362 | 0 | 1,222,211 | 1.2 M to 1.2 M (+4.12 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | C | 0.00 | 465,252 | 0 | 1,173,849 | 708.6 K to 1.2 M (+65.66 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | C | 0.00 | 273,468 | 0 | 708,597 | 435.1 K to 708.6 K (+62.85 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | QUAKER BIO VENTURES LP | 10% Owner | Buy | C | 0.00 | 399,201 | 0 | 435,129 | 35.9 K to 435.1 K (+1,111.11 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | C | 0.00 | 807,652 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | C | 0.00 | 5,376,964 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | C | 0.00 | 2,222,222 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | C | 0.00 | 1,458,333 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | C | 0.00 | 2,428,367 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | P | 4.00 | 359,310 | 1,437,240 | 1,114,759 | 755.4 K to 1.1 M (+47.56 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | C | 0.00 | 48,362 | 0 | 755,449 | 707.1 K to 755.4 K (+6.84 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | C | 0.00 | 321,973 | 0 | 707,087 | 385.1 K to 707.1 K (+83.60 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | C | 0.00 | 133,067 | 0 | 385,114 | 252 K to 385.1 K (+52.79 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | C | 0.00 | 87,325 | 0 | 252,047 | 164.7 K to 252 K (+53.01 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Clark B. Jefferson | Director | Buy | C | 0.00 | 145,411 | 0 | 164,722 | 19.3 K to 164.7 K (+753.00 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | McDonald Ellen | SVP & Chief Busines ... | Option Exercise | A | 4.00 | 51,092 | 204,368 | 51,092 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | BIODISCOVERY 3, FCPR | 10% Owner | Option Exercise | C | 0.00 | 2,832,872 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | BIODISCOVERY 3, FCPR | 10% Owner | Option Exercise | C | 0.00 | 17,066,243 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | BIODISCOVERY 3, FCPR | 10% Owner | Buy | P | 4.00 | 1,215,708 | 4,862,832 | 2,407,271 | 1.2 M to 2.4 M (+102.03 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | BIODISCOVERY 3, FCPR | 10% Owner | Buy | C | 0.00 | 169,633 | 0 | 1,191,563 | 1 M to 1.2 M (+16.60 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | BIODISCOVERY 3, FCPR | 10% Owner | Buy | C | 0.00 | 1,021,930 | 0 | 1,021,930 | 0 to 1 M |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Podlesak Dennis | Director | Option Exercise | A | 4.00 | 366,605 | 1,466,420 | 366,605 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Mazzo David J | President and CEO | Option Exercise | A | 4.00 | 558,167 | 2,232,668 | 558,167 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Rusconi Christopher Paul | Chief Scientific Of ... | Option Exercise | A | 4.00 | 59,880 | 239,520 | 59,880 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Courts Christopher | Vice President of F ... | Option Exercise | C | 0.00 | 90,277 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Courts Christopher | Vice President of F ... | Option Exercise | A | 4.00 | 25,965 | 103,860 | 25,965 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Courts Christopher | Vice President of F ... | Buy | C | 0.00 | 5,405 | 0 | 5,405 | 0 to 5.4 K |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Giaquinto Alexander R | CCO and SVP of Reg. ... | Option Exercise | A | 4.00 | 29,929 | 119,716 | 29,929 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Option Exercise | C | 0.00 | 22,878,805 | 0 | 0 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Buy | P | 4.00 | 3,866,529 | 15,466,116 | 5,236,517 | 1.4 M to 5.2 M (+282.23 %) |
| Aug 29 2013 | TBRA | Tobira Therapeutic ... | Gopka Anton | Director | Buy | C | 0.00 | 1,369,988 | 0 | 1,369,988 | 0 to 1.4 M |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 7,407 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 2,899 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 4,233 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 225,913 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 894,120 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 270,568 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Option Exercise | C | 0.00 | 394,969 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 7,407 | 0 | 14,920 | 7.5 K to 14.9 K (+98.59 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 2,899 | 0 | 7,513 | 4.6 K to 7.5 K (+62.83 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 4,233 | 0 | 4,614 | 381 to 4.6 K (+1,111.02 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | P | 4.00 | 750,000 | 3,000,000 | 2,571,117 | 1.8 M to 2.6 M (+41.18 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 225,913 | 0 | 1,821,117 | 1.6 M to 1.8 M (+14.16 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 894,120 | 0 | 1,595,204 | 701.1 K to 1.6 M (+127.53 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 270,568 | 0 | 701,084 | 430.5 K to 701.1 K (+62.85 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | VITULLO NICOLE | 10% Owner | Buy | C | 0.00 | 394,969 | 0 | 430,516 | 35.5 K to 430.5 K (+1,111.12 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | A | 4.00 | 17,964 | 71,856 | 17,964 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 7,407 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 2,899 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 4,233 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 225,913 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 894,120 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 270,568 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Option Exercise | C | 0.00 | 394,969 | 0 | 0 | |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 7,407 | 0 | 14,920 | 7.5 K to 14.9 K (+98.59 %) |
| Aug 28 2013 | TBRA | Tobira Therapeutic ... | TREU JESSE I | Director | Buy | C | 0.00 | 2,899 | 0 | 7,513 | 4.6 K to 7.5 K (+62.83 %) |